| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.8M | -7.4% |
| Cost of Revenue | $6.8M | +2.9% |
| Gross Profit | $16.0M | -11.2% |
| R&D Expense | $4.8M | -19.3% |
| SG&A Expense | $9.1M | +13.9% |
| Operating Income | -$1.7M | -187.7% |
| Interest Expense | $1.3M | -40.0% |
| Pre-tax Income | -$3.2M | -68.3% |
| Income Tax | $95K | +3066.7% |
| Net Income | -$3.2M | -73.1% |
| EPS (Basic) | -$0.07 | -75.0% |
| EPS (Diluted) | -$0.07 | -75.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | +27.2% |
| Accounts Receivable | $2.0M | -9.5% |
| Current Assets | $4.2M | +8.1% |
| Total Assets | $4.6M | -32.2% |
| Current Liabilities | $7.7M | +36.0% |
| Long-term Debt | $9.2M | +10.4% |
| Total Liabilities | $17.1M | +3.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $361K | +137.9% |
| Capital Expenditures | $40K | -37.5% |
| Investing Cash Flow | -$40K | +37.5% |
| Financing Cash Flow | $1.9M | +0.0% |
| Free Cash Flow | $321K | +131.6% |
| -$12.5M |
| -27.8% |